Inventor · disambiguated record
Larry A. Wheeler
Also filed as: WHEELER LARRY · WHEELER LARRY A · WHEELER LARRY ALLEN
77 granted patents·27 pending applications·1,845 citations·filing 1983–2019
99Inventor score
Top patents by PatentIndex Score
104 records- 0197US8293210B2Sustained release intraocular implants and methods for preventing retinal dysfunctionHUANG GLENN T·Filed 2007·Granted Oct 23, 2012·34 cites·6 claims
- 0297US7091232B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2003·Granted Aug 15, 2006·112 cites·3 claims
- 0397US6329369B1Methods of treating pain and other conditionsALLERGAN SALES INC·Filed 2000·Granted Dec 11, 2001·83 cites·17 claims
- 0497US6248741B1Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN SALES INC·Filed 2000·Granted Jun 19, 2001·98 cites·11 claims
- 0597US6194415B1Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injuryALLERGAN SALES INC·Filed 1999·Granted Feb 27, 2001·168 cites·6 claims
- 0696US6465464B2Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN INC·Filed 2002·Granted Oct 15, 2002·72 cites·16 claims
- 0794US6841684B2Imidiazoles having reduced side effectsALLERGAN INC·Filed 2001·Granted Jan 11, 2005·72 cites·18 claims
- 0893US5824685AMethod of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsUNIV JOHNS HOPKINS MED·Filed 1995·Granted Oct 20, 1998·79 cites·12 claims
- 0993US5721215AInjectable therapy for control of muscle spasms and pain related to muscle spasmsALLERGAN INC·Filed 1996·Granted Feb 24, 1998·112 cites·18 claims
- 1092US7767718B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Aug 3, 2010·7 cites·50 claims
- 1192US7323485B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Jan 29, 2008·7 cites·5 claims
- 1291US8425929B2Sustained release intraocular implants and methods for preventing retinal dysfunctionHUANG GLENN T·Filed 2004·Granted Apr 23, 2013·25 cites·4 claims
- 1391US7335803B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN INC·Filed 2001·Granted Feb 26, 2008·40 cites·3 claims
- 1490US8293741B2Intraocular implants and methods for improving visionBURKE JAMES A·Filed 2005·Granted Oct 23, 2012·15 cites·3 claims
- 1590US7345077B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2005·Granted Mar 18, 2008·12 cites·20 claims
- 1690US7125908B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2004·Granted Oct 24, 2006·21 cites·51 claims
- 1790US6313172B1Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·42 cites·10 claims
- 1889US7705055B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Apr 27, 2010·4 cites·46 claims
- 1989US7399868B24-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 15, 2008·11 cites·7 claims
- 2089US5756503AMethods for using (2-imidazolin-2-ylamino) Quinoxaline derivativesALLERGAN INC·Filed 1996·Granted May 26, 1998·55 cites·17 claims
- 2188US7419994B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Sep 2, 2008·8 cites·16 claims
- 2288US7060723B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2004·Granted Jun 13, 2006·18 cites·47 claims
- 2388US5863892AUse of platelet derived growth factor in ophthalmic wound healingALLERGAN INC·Filed 1994·Granted Jan 26, 1999·71 cites·15 claims
- 2488US5703077AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1996·Granted Dec 30, 1997·49 cites·19 claims
- 2587US7763651B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Jul 27, 2010·3 cites·50 claims
- 2687US6203794B1Modification of clostridial toxins for use as transport proteinsALLERGAN SALES INC·Filed 1995·Granted Mar 20, 2001·74 cites·14 claims
- 2787US5561132AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1995·Granted Oct 1, 1996·47 cites·17 claims
- 2886US9161938B2Sustained release intraocular implants and methods for treating ocular vasculopathiesHUANG GLENN T·Filed 2008·Granted Oct 20, 2015·6 cites·6 claims
- 2986US6075032AMethod of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsALLERGAN INC·Filed 1996·Granted Jun 13, 2000·46 cites·20 claims
- 3085US8153645B2Treating pain using selective antagonists of persistent sodium currentEHRING GEORGE R·Filed 2006·Granted Apr 10, 2012·3 cites·36 claims
- 3185US7358269B22-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-oneALLERGAN INC·Filed 2006·Granted Apr 15, 2008·6 cites·6 claims
- 3284US8506986B2Sustained release intraocular implants and methods for treating ocular vasculopathiesHUANG GLENN T·Filed 2008·Granted Aug 13, 2013·4 cites·1 claims
- 3383US7893107B2Therapeutic methods using prostaglandin EP4 agonist componentsALLERGAN INC·Filed 2005·Granted Feb 22, 2011·5 cites·10 claims
- 3483US7396849B24-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 3583US6372753B1Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsALLERGAN INC·Filed 2000·Granted Apr 16, 2002·12 cites·6 claims
- 3682US8063087B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compoundsCHOW KEN·Filed 2008·Granted Nov 22, 2011·4 cites·9 claims
- 3782US7683089B14-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Mar 23, 2010·4 cites·2 claims
- 3882US5773440AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1997·Granted Jun 30, 1998·32 cites·18 claims
- 3982US5552403AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1994·Granted Sep 3, 1996·28 cites·17 claims
- 4080US6323204B1Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1998·Granted Nov 27, 2001·46 cites·17 claims
- 4180US5856329AMethod of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN INC·Filed 1995·Granted Jan 5, 1999·50 cites·15 claims
- 4276US5587376AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1995·Granted Dec 24, 1996·24 cites·18 claims
- 4375US10201641B2Sustained release intraocular implants and methods for treating ocular vasculopathiesALLERGAN INC·Filed 2015·Granted Feb 12, 2019·1 cites·6 claims
- 4475US5714486AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1996·Granted Feb 3, 1998·22 cites·18 claims
- 4573US2010129435A1Methods and compositions for treatment of ocular neovascularization and neural injuryALLERGAN INC·Filed 2009·Application pending·0 cites
- 4671US8178571B2Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the sameHEIDELBAUGH TODD M·Filed 2010·Granted May 15, 2012·1 cites·7 claims
- 4771US7754768B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN INC·Filed 2008·Granted Jul 13, 2010·0 cites·3 claims
- 4870US6071924AMethod of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsALLERGAN INC·Filed 1998·Granted Jun 6, 2000·17 cites·17 claims
- 4970US5326763AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1993·Granted Jul 5, 1994·28 cites·16 claims
- 5070US5231096AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1992·Granted Jul 27, 1993·24 cites·17 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →